Literature DB >> 12813456

Interaction of the HPV E7 proteins with the pCAF acetyltransferase.

Nikita Avvakumov1, Joe Torchia, Joe S Mymryk.   

Abstract

Most cervical carcinomas express the E6 and E7 proteins of a high-risk human papillomavirus (HPV). These proteins affect growth control by interfering with the functions of cell regulatory proteins, promoting oncogenic transformation. A key target of E7 is the tumor suppressor protein pRb, which directly interacts with E7. However, binding to additional cellular regulatory proteins is clearly required for oncogenesis, as mutants of E7 have been identified that bind to pRb, yet fail to transform efficiently. Here we demonstrate the interaction of the HPV 6, 16 and 18 E7 proteins with the pCAF acetyltransferase, which has been reported to function as a coactivator for a variety of transcription factors including p53. Mutation of a highly conserved leucine residue within the zinc finger region of HPV 16 E7 disrupts binding to pCAF and also impairs transformation and transcriptional activation. HPV 16 E7 interacts with the acetyltransferase domain of pCAF, and reduces its acetyltransferase activity in vitro. Our analysis of the interaction between the pCAF acetyltransferase and E7 provides new insight into the mechanisms by which the E7 oncoproteins can alter cellular gene expression and growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813456     DOI: 10.1038/sj.onc.1206562

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation.

Authors:  Jailal N G Ablack; Michael Cohen; Gobi Thillainadesan; Gregory J Fonseca; Peter Pelka; Joe Torchia; Joe S Mymryk
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 4.  Genomic instability and cancer: lessons learned from human papillomaviruses.

Authors:  Nina Korzeniewski; Nicole Spardy; Anette Duensing; Stefan Duensing
Journal:  Cancer Lett       Date:  2010-11-13       Impact factor: 8.679

Review 5.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

Review 6.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

7.  Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1.

Authors:  Daniel C Anacker; Dipendra Gautam; Kenric A Gillespie; William H Chappell; Cary A Moody
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

8.  Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.

Authors:  Scott Balsitis; Fred Dick; Denis Lee; Linda Farrell; R Katherine Hyde; Anne E Griep; Nicholas Dyson; Paul F Lambert
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 9.  Viral manipulation of the host epigenome for oncogenic transformation.

Authors:  Roberto Ferrari; Arnold J Berk; Siavash K Kurdistani
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

10.  Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

Authors:  Sohrab Bodaghi; Rong Jia; Zhi-Ming Zheng
Journal:  Virology       Date:  2009-02-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.